Skip to main content
Department of Neurosciences Department of Neurosciences

Intervention Studies (Clinical Trials)

About Clinical Trials

An interventional study, or clinical trial, is a research study in which a human subject is assigned to one or more interventions (which may include an investigational drug, placebo, or other control) to evaluate the effects of those interventions on health-related or behavioral outcomes. 


Clinical Trials for Persons with Normal Cognition, Mild Cognitive Impairment (MCI), Early Alzheimer's Disease, and Other Dementias

The ADRC Clinical Trials Unit has a variety of clinical trials available for participants with Alzheimer's disease and related dementias. We continue to add new studies to our portfolio regularly and encourage individuals who are interested in participating to reach out to our team at the ADRC.

See below for studies currently in the pipeline that will be starting recruitment in the near future or download the clinical trials flyer (PDF) for more information.

TREAD: 'TREAD Eating Times for Alzheimer's Disease

Study Name TREAD Eating Times for Alzheimer's Disease
Study Summary

The purpose of this study is to investigate the safety, feasibility, and effectiveness of prolonged night fasting in reducing cognitive decline and disease markers in patients with mild cognitive impairment (MCI) or early to moderate Alzheimer’s disease (AD). Participants will follow a time-restricted eating (TRE) model of prolonged fasting during the night for 6 months. We will monitor blood-based markers of health, metabolism, aging, and AD pathology; record circadian regulation based on sleep and activity monitoring and evaluate cognitive functions over the course of 3 clinic visits.

Principal Investigator(s) Paula Desplats Ph.D. 
Required Diagnosis  Mild Cognitive Impairment (MCI), early stage Alzheimer's disease (AD) OR are healthy and are the living partner/spouse of a person diagnosed with Mild Cognitive Impairment or Alzheimer's Disease
Age 60 or older
Length 6 months
Lumbar Puncture ​No
MRI No
Amyloid PET No
Tau PET No
Compensation Yes; up to $225 for completion of all study visits and procedures
Contact

​pdesplat@health.ucsd.edu

o1ott@health.ucsd.edu

For More Information

2025-updatedTREAD-Flyer-High-Res.jpg

adobe-express-qr-code.pngScan or Click for more information

Brain Blast Video

 

PodCast Episode

Southern Caregiver Resource Center Podcast: Let's Talk Caregiving featured Dr. Desplats discussing AD Research and this project.  Click here to listen

Novartis VHB937

Study Novartis VHB937
Study Description This is a multicentre, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in participants with early AD followed by an Extension. The double-blind part is 72 weeks long, followed by an extension. The purpose of this study is to find out whether treatment with VHB937 is safe and beneficial in people with early Alzheimer's disease. The study will evaluate the safety of VHB937, as well as its effects on memory and other thinking abilities, on daily activities, and on changes in the brain. The study will also observe and measure how VHB937 is processed by the body and how the body responds to it.
PI Gabriel Leger, M.D.
Main Requirements
Age 50 - 85, must NOT be/have been on anti-amyloid monoclonal antibody therapy
Required Diagnosis Diagnosis of MCI due to AD or Early AD, biomarker confirmed (PET or CSF)
Age 50 - 85
Length 72 weeks
Lumbar Puncture Not required
MRI Yes
Amyloid PET Yes
Tau PET No
Compensation Yes
Contact clinicaltrialsADRC@health.ucsd.edu
For more information

Affiliated Research Groups

Virtual Reality Brain Health Study

Studies Virtual Reality Brain Health Study
Study Description The purpose of this study is to use a novel virtual reality (VR) based activity that simultaneously engages physical and cognitive activity aimed at improving brain health and cognition in older adults. We will compare 3 types of activities combined VR physical and cognitive, physical activity only, and VR cognitive activity only over 16 weeks to evaluate changes in brain health, cognition, blood-based biomarkers, and physical function in older adults.
PI Dr. Judy Pa
Main Requirements Between 50 and 85 years of age
Fluent in English
Can safely ride a stationary bike
Required Diagnosis No diagnosis required
Age 50-85 (inclusive)
Length Approx. 8-9 months including 4 months of active study participation and a follow-up visit 4 months later
Lumbar Puncture No
MRI 2 scans Required
Amyloid PET No
Tau PET No
Compensation Yes
Contact brainhealth@health.ucsd.edu
For more information

https://thepalab.com/participate/

Study Flyer (pdf)centers-programs/adrc/enrolling-studies/clinical-trials/Virtual-Reality-Brain-Health-Study-No-Stamp.pdf

QR Code qr code

Mente Sana/Mind Boost

Studies

 Mente Sana/Mind Boost Study

Study Description

 Kaiser Permanente Washington and the University of California San Diego (UCSD) are doing research to learn about different programs to improve the brain health of Hispanic/Latino(a) adults ages 55 and over. We are testing two different programs done independently at home: one is focused on gradually increasing physical activity; the other will focus on learning about healthy lifestyle changes that can help improve brain health. Both programs will be given over 12 weeks. Regardless of which program you end up in, they both fit within your daily life and are personalized to your situation and all activities in the study will be remote and done at your home. We developed the programs to work for people with different levels of ability, fitness, and health conditions.

PI

 Zvinka Zlatar (UCSD) and Dori Rosenberg (Kaiser Permanente Washington)

Main Requirements

  • Self identifying as Hispanic/Latino(a)
  • Speak English or Spanish
  • Have a smartphone and access to the internet
  • Are able to walk one block without help
  • Reside in Southern California

Required Diagnosis

Cognitively healthy

Age

55 to 89

Length

~20 weeks (12 weeks of intervention + up to 8 weeks of baseline and post intervention measurement assessments). All done at home. No need to travel anywhere. 

Lumbar Puncture

No

MRI

No

Amyloid PET

No

Tau PET

No

Compensation

Up to $100 for completing all measurement visits and a Fitbit Inspire device

Contact

Rosa Gutierrez Aceves at 858-822-7737

For more information

contact us at 858-822-7737

Study brochure in English and Spanish

mente sana mind boost